Let's see what mel brings to the table with aphy this week. Aphy did sixteen mm in revenue last year and will be a huge asset for compliance of medical marijuana.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.